148 related articles for article (PubMed ID: 2681903)
1. The value of mucin histochemistry, autoradiography and analysis of cellular DNA content for cancer surveillance in patients with ulcerative colitis.
Suzuki H; Matsumoto K
Jpn J Surg; 1989 Jul; 19(4):387-91. PubMed ID: 2681903
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
Brüwer M; Schmid KW; Senninger N; Schürmann G
World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
[TBL] [Abstract][Full Text] [Related]
3. Assessment of dysplasia, mucosal mucins, p53 protein expression, and DNA content in ulcerative colitis patients with colectomy and ileorectal anastomosis.
Navratil E; Stettler C; Paul G; Vilotte J; Vissuzaine C; Mignon M; Potet F
Scand J Gastroenterol; 1995 Apr; 30(4):361-6. PubMed ID: 7610353
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
[TBL] [Abstract][Full Text] [Related]
5. What is the likelihood of colorectal cancer when surgery for ulcerative-colitis-associated dysplasia is deferred?
Murphy J; Kalkbrenner KA; Blas JV; Pemberton JH; Landmann RG; Young-Fadok TM; Etzioni DA
Colorectal Dis; 2016 Jul; 18(7):703-9. PubMed ID: 26921877
[TBL] [Abstract][Full Text] [Related]
6. Ulcerative colitis-associated colorectal cancer.
Yashiro M
World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
[TBL] [Abstract][Full Text] [Related]
7. Dysplasia in ulcerative colitis--clinical consequences?
Sjöqvist U
Langenbecks Arch Surg; 2004 Oct; 389(5):354-60. PubMed ID: 15605166
[TBL] [Abstract][Full Text] [Related]
8. Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine: results from a 20-year surveillance study.
Lindberg BU; Broomé U; Persson B
Dis Colon Rectum; 2001 Jan; 44(1):77-85. PubMed ID: 11805567
[TBL] [Abstract][Full Text] [Related]
9. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
Fujii S; Fujimori T; Chiba T
J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases.
Florin TH; Pandeya N; Radford-Smith GL
Gut; 2004 Jul; 53(7):973-9. PubMed ID: 15194646
[TBL] [Abstract][Full Text] [Related]
12. Associations between markers of colorectal cancer stem cells, mutation, microRNA and the clinical features of ulcerative colitis.
Yang L; Levi E; Du JH; Zhou HH; Miller R; Majumdar AP
Colorectal Dis; 2016 Jun; 18(6):O185-93. PubMed ID: 27153478
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of colorectal cancer in patients with ulcerative colitis.
Higashi D; Futami K; Ishibashi Y; Egawa Y; Maekawa T; Matsui T; Iwashita A; Kuroki M
Anticancer Res; 2011 Jul; 31(7):2499-504. PubMed ID: 21873166
[TBL] [Abstract][Full Text] [Related]
15. A Panel of Methylated MicroRNA Biomarkers for Identifying High-Risk Patients With Ulcerative Colitis-Associated Colorectal Cancer.
Toiyama Y; Okugawa Y; Tanaka K; Araki T; Uchida K; Hishida A; Uchino M; Ikeuchi H; Hirota S; Kusunoki M; Boland CR; Goel A
Gastroenterology; 2017 Dec; 153(6):1634-1646.e8. PubMed ID: 28847750
[TBL] [Abstract][Full Text] [Related]
16. Ulcerative colitis and cancer.
Kulaylat MN; Dayton MT
J Surg Oncol; 2010 Jun; 101(8):706-12. PubMed ID: 20512947
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer and dysplasia risk of ulcerative colitis patients in a tertiary referral center in Turkey.
Ünal NG; Özütemiz Ö; Tekin F; Turan İ; Osmanoğlu N
Turk J Gastroenterol; 2019 Feb; 30(2):139-147. PubMed ID: 30460897
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological study of colorectal cancer occurring in patients with ulcerative colitis: results from a single hospital in Japan.
Fujita T; Ando T; Watanabe O; Hasegawa M; Miyake N; Kondo S; Kato T; Ishiguro K; Nakamura M; Miyahara R; Ohmiya N; Niwa Y; Goto H
Hepatogastroenterology; 2010; 57(99-100):487-92. PubMed ID: 20698214
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models.
Seril DN; Liao J; Yang GY; Yang CS
Carcinogenesis; 2003 Mar; 24(3):353-62. PubMed ID: 12663492
[TBL] [Abstract][Full Text] [Related]
20. Primary sclerosing cholangitis in ulcerative colitis--a risk factor for the development of dysplasia and DNA aneuploidy?
Broomé U; Lindberg G; Löfberg R
Gastroenterology; 1992 Jun; 102(6):1877-80. PubMed ID: 1587406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
